← All stocks

Quince Therapeutics, Inc.

QNCX Net selling
CIK 0001662774 #4870 in the set updated 18 Sep 2026
Bought (120 mo)
$11.88M
out of their own pocket, the only kind of buying there is
Sold (120 mo)
$29.23M
$0.00 on a plan · $9.71M straight out of an exercise
Sold at will
$19.52M
32 of 63 sales
Net
−$17.34M
−$7.63M against sales at will

By person

21 insiders · 141 transactions
6.2×

Dirk Thye holds 6.2 times base salary in stock. $3.45M of shares against $550.00K in salary for 2025.

Salary from the company's own proxy. The shares are what Dirk Thye last reported holding, valued at $3.47, the price Common Stock was last bought or sold at on the open market here, on 26 Dec 2025.

Insider
Role
Bought
Sold
Net
Holding
Worth
Change
PFIZER INC entity
10% owner
$850.00K (1)
$14.87M (1)
−$14.02M
2,879,973
$9.99M
Lamond David
Director
$8.65M (32)
+$8.65M
8,031,665
$27.87M
+120.2%
Lynch Casey
Chief Executive Officer
$4.41M (25)
−$4.41M
1,180,580
$4.10M
−4.8%
Detke Michael J.
Chief Medical Officer
$4.15M (9) scheduled
−$4.15M
140,000
$485.80K
LOWE CHRISTOPHER P.
Interim CEO, COO & CFO
$3.67M (10) scheduled
−$3.67M
265,000
$919.55K
EPIQ Capital Group, LLC entity
IA/Managing Member of 10% Owne
$1.33M (15)
+$1.33M
19,880,610
$68.99M
+0.1%
Holsinger Leslie
EVP, Preclinical Development
$1.23M (6) scheduled
−$1.23M
148,080
$513.84K
McLoughlin Margaret
Director
$19.19K (2)
$691.91K (9) scheduled
−$672.72K
8,000
$27.76K
YOUNG KEVIN
Director
$510.00K (1)
+$510.00K
30,000
$104.10K
Thye Dirk
CEO and CMO
$317.46K (4)
+$317.46K
994,885
$3.45M
+359.9%
Benatti Luca
Director
$173.50K (1)
−$173.50K
39,179
$135.95K
−51.2%
Hannah Brendan
CBO, COO & CCO
$111.72K (7)
+$111.72K
361,827
$1.26M
+218.6%
RYAN UNA S
Director
$48.88K (1)
+$48.88K
2,875
$9.98K
Ryan Charles S.
President
$31.45K (1)
+$31.45K
130,009
$451.13K
+75.5%
McDowell Caryn Gordon
Chief Legal & Adm. Officer
$30.92K (1)
−$30.92K
122,500
$425.08K
Dominy Stephen S.
Chief Scientific Officer
$10.99K (1)
+$10.99K
1,217,086
$4.22M
+0.1%
Monohon Ted
Chief Accounting Officer & VP
$1.83K (1)
−$1.83K
27,440
$95.22K
LAMOND PIERRE
10% owner
2,886,530
$10.02M
Takeda Ventures, Inc. entity
10% owner
2,679,802
$9.30M
Low Philip S
Director
519,283
$1.80M
Smith Karen L.
Chief Medical Officer
24,336
$84.45K

No percentages here. This company's share count has moved by a factor of 160.3 over the window, from 1,017,063 to 163,007,943 shares. A split, a merger or a large issue changes what the company is, and a holding measured at one point in that run is not a fraction of it at another.

Insider
Date
Role
Action
Shares
Price
Amount
Benatti Luca
26 Dec 2025
Director
Sell
50,000
$3.47
$173.50K
Hannah Brendan
5 Dec 2025
CBO, COO & CCO
Exercised, kept
25,280
$0.94
$23.76K
Hannah Brendan
5 Dec 2025
CBO, COO & CCO
Exercised, kept
2,271
$0.55
$1.25K
Thye Dirk
30 Aug 2024
CEO AND CHIEF MEDICAL OFFICER
Buy
77,000
$0.70
$53.90K
Thye Dirk
29 Aug 2024
CEO AND CHIEF MEDICAL OFFICER
Buy
77,500
$0.69
$53.48K
Hannah Brendan
21 Aug 2024
CHIEF BUSINESS OFFICER AND COO
Buy
23,565
$0.63
$14.85K
Hannah Brendan
21 Aug 2024
CHIEF BUSINESS OFFICER AND COO
Buy
5,000
$0.62
$3.10K
Hannah Brendan
21 Aug 2024
CHIEF BUSINESS OFFICER AND COO
Buy
2,280
$0.61
$1.39K
Hannah Brendan
20 Aug 2024
CHIEF BUSINESS OFFICER AND COO
Buy
3,424
$0.60
$2.05K
Hannah Brendan
20 Aug 2024
CHIEF BUSINESS OFFICER AND COO
Buy
2,500
$0.61
$1.53K
Ryan Charles S.
20 Aug 2024
PRESIDENT
Buy
48,387
$0.65
$31.45K
Hannah Brendan
19 Aug 2024
CHIEF BUSINESS OFFICER AND COO
Buy
2,155
$0.58
$1.25K
Hannah Brendan
4 Jun 2024
CHIEF BUSINESS OFFICER AND COO
Exercised, kept
56,061
$0.55
$30.83K
Thye Dirk
16 Jan 2024
CHIEF EXECUTIVE OFFICER
Exercised, kept
149,999
$0.94
$141.00K
Thye Dirk
16 Jan 2024
CHIEF EXECUTIVE OFFICER
Exercised, kept
90,531
$0.55
$49.79K
Lamond David
14 Dec 2023
Director
Buy indirect
22,627
$1.04
$23.53K
Lamond David
13 Dec 2023
Director
Buy indirect
22,627
$1.00
$22.63K
Lamond David
12 Dec 2023
Director
Buy
22,327
$1.02
$22.77K
Lamond David
12 Dec 2023
Director
Buy indirect
300
$1.00
$300.00
Lamond David
7 Dec 2023
Director
Buy indirect
19,123
$1.01
$19.31K
Lamond David
6 Dec 2023
Director
Buy indirect
19,123
$1.02
$19.51K
Lamond David
5 Dec 2023
Director
Buy indirect
19,123
$1.01
$19.31K
Lamond David
1 Dec 2023
Director
Buy indirect
14,378
$0.94
$13.52K
Lamond David
30 Nov 2023
Director
Buy indirect
14,378
$0.90
$12.94K
Lamond David
29 Nov 2023
Director
Buy indirect
14,378
$0.98
$14.09K
Lamond David
31 Aug 2023
Director
Buy indirect
41,026
$1.32
$54.15K
Lamond David
30 Aug 2023
Director
Buy indirect
41,026
$1.31
$53.74K
Lamond David
17 Aug 2023
Director
Buy indirect
24,766
$1.29
$31.95K
Lamond David
16 Aug 2023
Director
Buy indirect
117,348
$1.29
$151.38K
Lamond David
15 Aug 2023
Director
Buy indirect
107,886
$1.32
$142.41K
Thye Dirk
10 Aug 2023
Chief Executive Officer
Buy
88,000
$1.26
$110.88K
McLoughlin Margaret
8 Aug 2023
Director
Buy
8,000
$1.23
$9.84K
Hannah Brendan
8 Aug 2023
Chief Business Officer
Buy
71,762
$1.22
$87.55K
Thye Dirk
8 Aug 2023
Chief Executive Officer
Buy
80,000
$1.24
$99.20K
Monohon Ted
6 Mar 2023
Chief Accounting Officer & VP
Sell
1,871
$0.98
$1.83K
McDowell Caryn Gordon
6 Jun 2022
Chief Legal & Adm. Officer
Sell
10,800
$2.86
$30.92K
Lynch Casey
18 Nov 2021
Chief Executive Officer
Exercised, kept
60,000
$0.46
$27.60K
LOWE CHRISTOPHER P.
16 Nov 2021
COO & Chief Financial Officer
Exercised, kept
30,000
$2.23
$66.90K
Dominy Stephen S.
12 Nov 2021
Chief Scientific Officer
Buy indirect
763
$14.40
$10.99K
McLoughlin Margaret
8 Oct 2021
Director
Sold after exercise
1,000
$88.93
$88.93K
LOWE CHRISTOPHER P.
5 Oct 2021
COO & Chief Financial Officer
Sold after exercise
4,963
$98.50
$488.86K
LOWE CHRISTOPHER P.
17 Aug 2021
COO & Chief Financial Officer
Exercised, kept
30,000
$2.23
$66.90K
LOWE CHRISTOPHER P.
16 Aug 2021
COO & Chief Financial Officer
Sold after exercise
2,077
$98.90
$205.42K
LOWE CHRISTOPHER P.
16 Aug 2021
COO & Chief Financial Officer
Sold after exercise
1,100
$97.28
$107.01K
LOWE CHRISTOPHER P.
16 Aug 2021
COO & Chief Financial Officer
Sold after exercise
2,330
$96.32
$224.43K
LOWE CHRISTOPHER P.
16 Aug 2021
COO & Chief Financial Officer
Sold after exercise
7,335
$95.02
$696.97K
LOWE CHRISTOPHER P.
16 Aug 2021
COO & Chief Financial Officer
Sold after exercise
9,158
$94.23
$862.96K
McLoughlin Margaret
16 Aug 2021
Director
Sold after exercise
48
$98.90
$4.75K
McLoughlin Margaret
16 Aug 2021
Director
Sold after exercise
423
$97.55
$41.26K
McLoughlin Margaret
16 Aug 2021
Director
Sold after exercise
1,429
$96.51
$137.91K
McLoughlin Margaret
16 Aug 2021
Director
Sold after exercise
1,044
$95.57
$99.78K
McLoughlin Margaret
16 Aug 2021
Director
Sold after exercise
3,056
$94.55
$288.94K
Detke Michael J.
10 Aug 2021
Chief Medical Officer
Sold after exercise
10,000
$100.00
$1.00M
Detke Michael J.
7 Jul 2021
Chief Medical Officer
Sold after exercise
523
$56.99
$29.81K
Detke Michael J.
7 Jul 2021
Chief Medical Officer
Sold after exercise
6,942
$56.27
$390.63K
Detke Michael J.
7 Jul 2021
Chief Medical Officer
Sold after exercise
4,353
$55.38
$241.07K
Detke Michael J.
7 Jul 2021
Chief Medical Officer
Sold after exercise
1,648
$54.37
$89.60K
Detke Michael J.
7 Jul 2021
Chief Medical Officer
Sold after exercise
3,934
$53.24
$209.45K
Detke Michael J.
6 Jul 2021
Chief Medical Officer
Sold after exercise
288
$55.01
$15.84K
Detke Michael J.
6 Jul 2021
Chief Medical Officer
Sold after exercise
8,260
$53.91
$445.30K
Detke Michael J.
6 Jul 2021
Chief Medical Officer
Sold after exercise
32,313
$53.43
$1.73M
LOWE CHRISTOPHER P.
30 Jun 2021
COO & Chief Financial Officer
Exercised, kept
30,000
$2.23
$66.90K
McLoughlin Margaret
28 Jun 2021
Director
Sell
100
$55.73
$5.57K
McLoughlin Margaret
28 Jun 2021
Director
Sell
250
$55.03
$13.76K
McLoughlin Margaret
28 Jun 2021
Director
Sell
200
$55.01
$11.00K
LOWE CHRISTOPHER P.
28 Jun 2021
COO & Chief Financial Officer
Sold after exercise
1,044
$56.16
$58.63K
LOWE CHRISTOPHER P.
28 Jun 2021
COO & Chief Financial Officer
Sold after exercise
4,153
$55.11
$228.87K
LOWE CHRISTOPHER P.
28 Jun 2021
COO & Chief Financial Officer
Sold after exercise
7,079
$54.13
$383.19K
LOWE CHRISTOPHER P.
28 Jun 2021
COO & Chief Financial Officer
Sold after exercise
7,724
$53.39
$412.38K
Lynch Casey
10 May 2021
Chief Executive Officer
Sell indirect
183
$36.73
$6.72K
Lynch Casey
10 May 2021
Chief Executive Officer
Sell indirect
6,315
$35.81
$226.14K
Lynch Casey
10 May 2021
Chief Executive Officer
Sell indirect
9,918
$34.89
$346.04K
Lynch Casey
10 May 2021
Chief Executive Officer
Sell indirect
13,584
$33.75
$458.46K
Lamond David
24 Mar 2021
Director
Buy indirect
50,000
$33.77
$1.69M
Lynch Casey
22 Mar 2021
Chief Executive Officer
Sell indirect
400
$36.60
$14.64K
Lynch Casey
22 Mar 2021
Chief Executive Officer
Sell indirect
300
$36.58
$10.97K
Lynch Casey
22 Mar 2021
Chief Executive Officer
Sell indirect
18,089
$35.85
$648.49K
Lynch Casey
22 Mar 2021
Chief Executive Officer
Sell indirect
11,211
$35.10
$393.51K
Lamond David
4 Mar 2021
Director
Buy indirect
4,100
$36.86
$151.13K
Lamond David
4 Mar 2021
Director
Buy indirect
15,969
$36.34
$580.31K
Lamond David
4 Mar 2021
Director
Buy indirect
13,310
$35.00
$465.85K
Lamond David
4 Mar 2021
Director
Buy indirect
16,621
$34.28
$569.77K
Lynch Casey
3 Feb 2021
Chief Executive Officer
Sell indirect
600
$45.73
$27.44K
Lynch Casey
3 Feb 2021
Chief Executive Officer
Sell indirect
8,032
$45.00
$361.44K
Lynch Casey
3 Feb 2021
Chief Executive Officer
Sell indirect
1,900
$44.22
$84.02K
Lynch Casey
3 Feb 2021
Chief Executive Officer
Sell indirect
1,512
$43.10
$65.17K
Lynch Casey
3 Feb 2021
Chief Executive Officer
Sell indirect
3,100
$41.91
$129.92K
Lynch Casey
3 Feb 2021
Chief Executive Officer
Sell indirect
2,000
$40.84
$81.68K
Lynch Casey
3 Feb 2021
Chief Executive Officer
Sell indirect
856
$39.82
$34.09K
Lynch Casey
3 Feb 2021
Chief Executive Officer
Sell indirect
1,600
$38.64
$61.82K
Lynch Casey
3 Feb 2021
Chief Executive Officer
Sell indirect
400
$37.39
$14.96K
Lynch Casey
2 Feb 2021
Chief Executive Officer
Sell indirect
5,071
$36.75
$186.36K
Lynch Casey
2 Feb 2021
Chief Executive Officer
Sell indirect
14,929
$36.02
$537.74K
Lynch Casey
1 Feb 2021
Chief Executive Officer
Sell indirect
371
$39.23
$14.55K
Lynch Casey
1 Feb 2021
Chief Executive Officer
Sell indirect
100
$38.28
$3.83K
Lynch Casey
1 Feb 2021
Chief Executive Officer
Sell indirect
4,283
$37.68
$161.38K
Lynch Casey
1 Feb 2021
Chief Executive Officer
Sell indirect
7,460
$36.56
$272.74K
Lynch Casey
1 Feb 2021
Chief Executive Officer
Sell indirect
3,100
$35.59
$110.33K
Lynch Casey
1 Feb 2021
Chief Executive Officer
Sell indirect
4,686
$34.60
$162.14K
Holsinger Leslie
14 Dec 2020
Executive Vice President
Sold after exercise
900
$32.59
$29.33K
Holsinger Leslie
14 Dec 2020
Executive Vice President
Sold after exercise
400
$32.59
$13.03K
Holsinger Leslie
14 Dec 2020
Executive Vice President
Sold after exercise
9,525
$31.79
$302.80K
Holsinger Leslie
14 Dec 2020
Executive Vice President
Sold after exercise
13,200
$30.91
$408.01K
Holsinger Leslie
14 Dec 2020
Executive Vice President
Sold after exercise
14,275
$30.15
$430.39K
Holsinger Leslie
14 Dec 2020
Executive Vice President
Sold after exercise
1,700
$28.80
$48.96K
Holsinger Leslie
10 Dec 2020
Executive Vice President
Exercised, kept
3,500
$0.27
$945.00
EPIQ Capital Group, LLC
12 Jun 2020
IA/Managing Member of 10% Owne
Buy indirect
2,440
$44.06
$107.51K
EPIQ Capital Group, LLC
11 Jun 2020
IA/Managing Member of 10% Owne
Buy indirect
6,600
$44.32
$292.51K
Lamond David
4 Jun 2020
Director
Buy indirect
24,874
$43.88
$1.09M
Lamond David
4 Jun 2020
Director
Buy indirect
10,642
$43.32
$461.03K
Lamond David
4 Jun 2020
Director
Buy indirect
13,609
$42.13
$573.38K
PFIZER INC
3 Jun 2020
10% owner
Sell
370,000
$40.18
$14.87M
Detke Michael J.
27 May 2020
Chief Medical Officer
Exercised, kept
5,515
$6.91
$38.11K
EPIQ Capital Group, LLC
22 May 2020
IA/Managing Member of 10% Owne
Buy indirect
2,085
$55.90
$116.55K
EPIQ Capital Group, LLC
21 May 2020
IA/Managing Member of 10% Owne
Buy indirect
520
$55.80
$29.02K
EPIQ Capital Group, LLC
20 May 2020
IA/Managing Member of 10% Owne
Buy indirect
417
$57.22
$23.86K
EPIQ Capital Group, LLC
20 May 2020
IA/Managing Member of 10% Owne
Buy indirect
5,668
$58.00
$328.74K
Lamond David
19 May 2020
Director
Buy indirect
32,894
$56.42
$1.86M
Lamond David
19 May 2020
Director
Buy indirect
5,906
$55.42
$327.31K
Lamond David
19 May 2020
Director
Buy indirect
400
$54.09
$21.64K
Lamond David
15 May 2020
Director
Buy indirect
100
$53.10
$5.31K
Lamond David
15 May 2020
Director
Buy indirect
500
$52.20
$26.10K
Lamond David
15 May 2020
Director
Buy indirect
1,000
$50.71
$50.71K
Lamond David
15 May 2020
Director
Buy indirect
1,600
$48.96
$78.33K
Lamond David
15 May 2020
Director
Buy indirect
985
$48.37
$47.64K
Lamond David
15 May 2020
Director
Buy indirect
1,263
$46.30
$58.48K
Detke Michael J.
2 Apr 2020
Chief Medical Officer
Exercised, kept
5,515
$6.91
$38.11K
Detke Michael J.
7 Feb 2020
Chief Medical Officer
Exercised, kept
17,231
$6.91
$119.07K
EPIQ Capital Group, LLC
21 Aug 2019
IA/Managing Member 10% owner
Buy
1,635
$24.87
$40.66K
EPIQ Capital Group, LLC
21 Aug 2019
IA/Managing Member 10% owner
Buy indirect
420
$24.87
$10.44K
EPIQ Capital Group, LLC
20 Aug 2019
IA/Managing Member 10% owner
Buy
2,310
$25.69
$59.34K
EPIQ Capital Group, LLC
20 Aug 2019
IA/Managing Member 10% owner
Buy indirect
600
$25.69
$15.41K
EPIQ Capital Group, LLC
19 Aug 2019
IA/Managing Member 10% owner
Buy indirect
2,100
$26.50
$55.64K
EPIQ Capital Group, LLC
16 Aug 2019
IA/Managing Member 10% owner
Buy indirect
700
$26.37
$18.46K
PFIZER INC
13 May 2019
10% owner
Buy
50,000
$17.00
$850.00K
McLoughlin Margaret
13 May 2019
Director
Buy
550
$17.00
$9.35K
RYAN UNA S
13 May 2019
Director
Buy indirect
2,875
$17.00
$48.88K
YOUNG KEVIN
13 May 2019
Director
Buy
30,000
$17.00
$510.00K
EPIQ Capital Group, LLC
10 May 2019
IA/Managing Member 10% owner
Buy indirect
80
$27.05
$2.16K
EPIQ Capital Group, LLC
10 May 2019
IA/Managing Member 10% owner
Buy indirect
4,170
$27.58
$115.01K
EPIQ Capital Group, LLC
10 May 2019
IA/Managing Member 10% owner
Buy
4,350
$26.41
$114.88K

What was left out

Form 4 filings counted 164
Amendments (4/A) skipped 6
Filings about a different issuer 0
Unreadable filings 0
Joint filings 10
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 31
Sales at will 32
Transactions with no price 0
Shares from compensation/vesting 16,076,553
Sales filed before the plan box existed 31
History held since 9 May 2019